MTIM
GOSS icon

Marathon Trading Investment Management’s Gossamer Bio GOSS Stock Holding History

Marathon Trading Investment Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,625
Closed -$248K – 336
2024
Q1 		$248K Buy
+2,625
New +$231K 0.02% 242

Other funds holding GOSS

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Marathon Trading Investment Management's GOSS Position: Q2 2024 in Review

Marathon Trading Investment Management sold out of Gossamer Bio (GOSS) in Q2 2024, closing a stake of 2,625 shares — an estimated $248K sold.

Marathon Trading Investment Management first reported a position in GOSS in Q1 2024 and held it in 1 quarter. The position peaked at $248K in Q1 2024. 93 funds tracked by Wall St. Rank hold GOSS as of Q2 2024.

  • Marathon Trading Investment Management reported no remaining Gossamer Bio position as of Q2 2024 after selling out during the quarter.
  • Marathon Trading Investment Management sold 2,625 Gossamer Bio shares in Q2 2024, an estimated $248K.
  • Marathon Trading Investment Management first reported a position in Gossamer Bio in Q1 2024 and held it in 1 quarter.
  • Marathon Trading Investment Management's Gossamer Bio position peaked at $248K in Q1 2024.
  • 93 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2024.

Based on Marathon Trading Investment Management's 13F filing for Q2 2024, filed 12 Aug 2024.